MEDARTIS: Medartis’ strong focus on trauma will be key in this challenging environment | BUY | CHF57 vs. CHF64 (+46%)
MEDARTIS - BUY | CHF57 vs. CHF64 (+46%)Medartis’ strong focus on trauma will be key in this challenging environment
2020 guidance withdrawn due to global spread of Covid-19
Strong disruption in procedures, but traumatology is less affected
Medartis should benefit from the resilience of trauma
A well experienced executive to take over US business
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.